RxDoctor Payments Data

Josephine Karl, PA

Surgical · Dallas, TXNPI 1316051071

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.0% of the total across 919 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Among surgical clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,462in general payments, 2019–2025

Across 919 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Johnson & Johnson$2K
  • Sun Pharmaceutical Industries Inc.$2K
  • Amgen$1K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Novartis$977
  • plus $8K from 22 others

What the payments were for

  • Food & beverage$17,35594%
  • Education$1,1076%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,462 in reported general payments places this provider in the 95th percentile of 804 surgical providers in Texas.

See all surgical providers in Texas

Medicare billing

Part B allowed, 2024
$97,176
Medicare patients
449
Services billed
9,388

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab41$163,571
Betamethasone Dipropionate109$4,232
Clobetasol Propionate74$4,062
Doxycycline Hyclate83$3,253
Triamcinolone Acetonide146$2,716
Ketoconazole112$2,198
Tacrolimus13$1,943
Imiquimod44$1,793
Hydrocortisone71$875
Clindamycin Phosphate27$857
Metronidazole19$651
ValacyclovirValacyclovir Hcl22$467
Mupirocin42$351
Spironolactone21$173
Hydroxyzine Hcl15$122

Paid to pharmacies, not to this prescriber.

Other surgical in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →